Home Economy News US Congress spending plan backs Israel, extends anti-AIDS program

US Congress spending plan backs Israel, extends anti-AIDS program


US Congress spending plan backs Israel, extends anti-AIDS program By Reuters

Breaking News



Published Mar 21, 2024 02:40PM ET
Updated Mar 21, 2024 02:56PM ET

© Reuters. U.S. Senator Chris Van Hollen (D-MD) speaks during a press conference addressing a new policy that demands recipients of foreign military aid to follow international humanitarian law at the U.S. Capitol in Washington, U.S., February 9, 2024. REUTERS/Natha

By Patricia Zengerle

WASHINGTON (Reuters) – Foreign policy provisions in the $1.2 trillion spending plan unveiled by U.S. congressional leaders on Thursday included billions of dollars in military spending, concessions to Israel and a long-awaited extension of PEPFAR, a life-saving program to fight AIDS.

As Reuters reported on Tuesday, the State Department appropriations bill continues a ban on U.S. funding for UNRWA, the main U.N. agency for Palestinians, for at least a year. It also eliminates funding for the UN Commission of Inquiry against Israel and fully funds the annual U.S. security commitment of $3.3 billion for Israel.

President Joe Biden’s administration said in January it was temporarily pausing new funding to the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA) after Israel accused 12 of the agency’s 13,000 employees in Gaza of participating in the deadly Oct. 7 Hamas attack.

Backers of the aid have been trying to get it restored, calling on Washington to support the relief body as relief groups work to ward off famine in Gaza.

Senator Chris Van Hollen, a Democrat who has argued that UNRWA remains essential to save lives, said the decision was “unconscionable,” given the humanitarian catastrophe in Gaza.

“UNWRA is the primary means of distributing desperately-needed assistance in Gaza – so denying funding for UNRWA is tantamount to denying food to starving people and restricting medical supplies to injured civilians,” he said in a statement.

The State Department funding bill also includes a one-year reauthorization of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). PEPFAR began in 2003 under Republican President George W. Bush and enjoyed bipartisan support until recently. The program was renewed 5-1/2 years ago by unanimous consent – with no objections from either Republicans or Democrats.

But this year, Republican opponents of abortion rights came out against a five-year reauthorization. Advocates say PEPFAR does not fund or provide abortion services and that none of its money goes directly or indirectly to fund abortion services.

The State Department says more than $100 billion has been spent on the global HIV/AIDS response through the program, which has saved 25 million lives.

The Defense Appropriations bill covers a record $886 billion in annual military spending, which was authorized in the National Defense Authorization Act, or NDAA, passed last year.

US Congress spending plan backs Israel, extends anti-AIDS program

Our Apps

Terms And Conditions
Privacy Policy
Risk Warning
Do not sell my personal information

© 2007-2024 Fusion Media Limited. All Rights Reserved.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Related News